×
For best experience we recommend to activate Javascript in your browser.
MAB21L2 antibody (AA 185-219)
This Rabbit Polyclonal antibody specifically detects MAB21L2 in WB. It exhibits reactivity toward Zebrafish (Danio rerio).
Catalog No. ABIN6244244
$451.00
Plus shipping costs $50.00
80 μL ABIN6577575
400 μL ABIN6244244
80 μL ABIN6577575
400 μL ABIN6244244
Delivery in 10 to 12 Business Days
Quick Overview for MAB21L2 antibody (AA 185-219) (ABIN6244244)
Target
See all MAB21L2 Antibodies
MAB21L2
(Mab-21-Like 2 (MAB21L2))
Reactivity
All reactivities for MAB21L2 antibodies
Zebrafish (Danio rerio)
Host
All hosts for MAB21L2 antibodies
Rabbit
Clonality
All clonalities for MAB21L2 antibodies
Polyclonal
Conjugate
All conjugates for MAB21L2 antibodies
This MAB21L2 antibody is un-conjugated
Application
All applications for MAB21L2 antibodies
Western Blotting (WB)
Clone
RB46517
Product Details anti-MAB21L2 Antibody
(hide)
Binding Specificity
AA 185-219
Predicted Reactivity
H, M
Purification
This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This (DANRE) mab21l2 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 185-219 amino acids from the Central region of human (DANRE) mab21l2.
Isotype
Ig Fraction
Alternatives
(show)
Application Details
(hide)
Application Notes
WB: 1:1000
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Expiry Date
6 months
Target Details for MAB21L2
(hide)
Target
MAB21L2
(Mab-21-Like 2 (MAB21L2))
Alternative Name
mab21l2
Background
Required for eye morphogenesis. May promote the survival of proliferating retinal progenitor cells.
Molecular Weight
41014
UniProt
Q8UUZ1
Pathways
Embryonic Body Morphogenesis
Recently viewed
(hide)
Chat with us , powered by LiveChat